VRNA - Verona Pharma plc Sof marja

Verona Pharma PLC (VRNA) - korporativ logo

Verona Pharma plc (VRNA) kompaniyasining sof marja dinamikasi kompaniyaning FDA tasdig'i va patent himoyasiga bog'liqligini aks ettiradi. Global mojarolardan kelib chiqadigan logistik murakkabliklar xatarlarni yuzaga keltirmoqda, garchi G'arb bozorlariga e'tibor qaratingan holda muhitni barqarorlashtirsa-da. Joriy daromadlilik tendentsiyasi ushbu grafikda ko'rinib turibdi, bunda -36.40 joriy parametr qiymati bo'lib xizmat qiladi va mahsulotni joriy etish samaradorligini baholashga yordam beradi.

Verona Pharma Inc. (VRNA) Sotuvning sof rentabelligi: 04.07.2022 - 18.10.2025 davri uchun

Verona Pharma Inc. (VRNA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning umumiy tahlili:Verona Pharma - VRNA
Verona Pharma Corp tayyor mahsulotlari

Sotuv marjalari daromadning har bir rublidagi sof foyda ulushini belgilab, xarajatlarni boshqarish samaradorligini va biznesning yakuniy daromadliligini o'lchaydi. Tijorat faoliyatining sof marjasini tahlil qilish Verona Pharma plc (VRNA) salohiyatini baholash imkonini beradi: qimmat klinika sinovlari yakunlanganidan so'ng, ommaviy tarqatish davrida dori sintezining past tannarxi ushbu ko'rsatkichning keskin o'sishini ta'minlashi kerak.

Verona Pharma plc kimlar bilan raqobatlashadi

HLN: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi KVUE|Sof marja Jyong Biotech Ltd|Sotuvning sof marjinal rentabelligi Ligand Corp|Sotuvning sof marjinal rentabelligi AMRX|Kompaniya sotuv marjasi Perrigo Company plc|Sotuvning sof marjinal rentabelligi ALVO (Alvotech Biopharmaceuticals)|LQDA: Sotuvning sof rentabelligi|Galapagos N.V. - Sotuvning sof marjinal rentabelligi|ANIP - Sotuvning sof marjinal rentabelligi|MNKD: Sotuvning sof marjinal rentabelligi|amphastar.com (AMPH) - Sotuvning sof marjinal rentabelligi|PCRX (Pacira Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ARS Pharmaceuticals, Inc. (SPRY)|Sotuvning sof marjinal rentabelligi TBPH|AQST (Aquestive Therapeutics) - Sof foyda normasi|scPharmaceuticals, Inc. - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi TECX|tonixpharma.com - Sotuvning sof marjinal rentabelligi|Sof foyda normasi SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Sof marja|Sof foyda bo'yicha sotuv rentabelligi BioHarvest|Sof foyda bo'yicha sotuv rentabelligi EXOZ|Sof foyda bo'yicha sotuv rentabelligi Oramed Pharmaceuticals (ORMP)|Sof foyda bo'yicha sotuv rentabelligi ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi ABVC (ABVC BioPharma Inc)|CPIX - Sof foyda bo'yicha sotuv rentabelligi|Quantum BioPharma Corp - Sotuvning sof marjinal rentabelligi|FGEN (fibrogen.com) - Sotuvning sof rentabelligi|TELO (Telomir Pharmaceuticals) - Sof foyda bo'yicha sotuv rentabelligi|Rani Therapeutics Holdings - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi SNYR|Sof marja rallybio.com RLYB|Sotuvning sof marjinal rentabelligi LEXX|PULM (Pulmatrix, Inc.) - Sof foyda normasi|Pheton Holdings - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Aptorum Group Limited APM|LYRA: Sof foyda bo'yicha sotuv rentabelligi|IBO: Sof marja|TNFA: Sotuvning sof marjinal rentabelligi|YCBD: Kompaniyaning sof rentabelligi|Sof marja PainReform Ltd|CYTO (altamiratherapeutics.com) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi LIPO|OPTN - Sof marja|Sof marja pieris.com PIRS|Sof foyda normasi PROC|PTPI - Sof marja|Qilian International Holding (QLI) - Sof foyda bo'yicha sotuv rentabelligi|SLRN: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi TFF Pharma